Total Funding
7
11
Total FundingGrant raised
Growth Score
-2 pts
Heat Score
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
477262
Treeway accelerates ALS (Amyotrophic Lateral Sclerosis) therapy development.
- Ronald van der Geest: Chief Development Officer (CDO)Past Role: Kinesis Pharma B.V., CDO
- Past Role: ALS Investment Fund, Board Member Qurit Alliance
About the Company
Treeway has been formed by the words tree of life and pathway of a disease, for the founders the symbolic way towards a cure. We foresee that medication, research and care will change dramatically in the coming decades and patients will become an essential part of this process in their pursuit for cures in rare and common diseases.
Everyone can
make a difference and our slogan "one man can and will find a way, why not be that man?" underpins our drive.
It is our mission to speed up research for ALS in collaboration with academic and research centers around the globe. We thrive to inspire them with our drive for accelerating therapies and drug development for ALS and aim to have new therapies in the market before the end of 2014.
